Loading...
In Vitro Activity of Meropenem-Vaborbactam against Clinical Isolates of KPC-Positive Enterobacteriaceae
Vaborbactam (formerly RPX7009) is a novel inhibitor of serine β-lactamases, including Ambler class A carbapenemases, such as KPCs. The current study evaluated the in vitro activity of the combination agent meropenem-vaborbactam against a global collection of 991 isolates of KPC-positive Enterobacter...
Na minha lista:
| Udgivet i: | Antimicrob Agents Chemother |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5740317/ https://ncbi.nlm.nih.gov/pubmed/29084745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01904-17 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|